Keymed (康诺亚生物) IPO Trading: CDE Consultation Paper Marginally Positive for Pipeline
We look at the updates of Keymed IPO since our last note. Sentiments were positive for the deal as we have expected. The recent CDE consultation...
486 Views
ECM Weekly (4th July 2021) - Xpeng, Medbot, Medlive, Brii Bio, CTOS, LinkDoc, Devyani, Manycore
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
795 Views
3SBio Inc (1530.HK) - The Concerns and the Outlook
This insight mainly analyzed the potential reasons behind the decline in 3SBio Group's share price, the important products, the pipeline, the...
434 Views
ECM Weekly (27th June 2021) - Didi, Xpeng, Zylox, Dingdong, EBeauty, Chaoju Eye Care, Keymed Bio
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
707 Views
Keymed (康诺亚生物) IPO: A Free Option for Overseas Potential
Keymed's IPO valuation only reflects the value derived from China market. The value derived from the overseas market will be the free option for...
738 Views